Englander Institute for Precision Medicine
Found 797 results
Author Title Type [ Year(Asc)]
Filters: Corrigendum-whole-genome-and-transcriptome-analysis-pancreatic-acinar-cell-carcinoma is   [Clear All Filters]
2023
Gillessen S, Bossi A, Davis ID, de Bono J, Fizazi K, James ND, Mottet N, Shore N, Small E, Smith M et al..  2023.  Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022.. Eur Urol. 83(3):267-293.
Gillessen S, Bossi A, Davis ID, de Bono J, Fizazi K, James ND, Mottet N, Shore N, Small E, Smith M et al..  2023.  Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022.. Eur J Cancer. 185:178-215.
Hegewisch-Solloa E, Melsen JE, Ravichandran H, Rendeiro AF, Freud AG, Mundy-Bosse B, Melms JC, Eisman SE, Izar B, Grunstein E et al..  2023.  Mapping human natural killer cell development in pediatric tonsil by imaging mass cytometry and high-resolution microscopy.. bioRxiv.
Pandey RS, Arnold M, Batra R, Krumsiek J, Kotredes KP, Garceau D, Williams H, Sasner M, Howell GR, Kaddurah-Daouk R et al..  2023.  Metabolomics profiling reveals distinct, sex-specific signatures in the serum and brain metabolomes in the mouse models of Alzheimer's disease.. bioRxiv.
López-Otín C, Pietrocola F, Roiz-Valle D, Galluzzi L, Kroemer G.  2023.  Meta-hallmarks of aging and cancer.. Cell Metab. 35(1):12-35.
Huang SH, Sartorello G, Shen P-T, Xu C, Elemento O, Shvets G.  2023.  Metasurface-enhanced infrared spectroscopy in multiwell format for real-time assaying of live cells.. Lab Chip. 23(9):2228-2240.
Pulcrano S, De Gregorio R, De Sanctis C, Volpicelli F, Piscitelli RMaria, Speranza L, Perrone-Capano C, di Porzio U, Caiazzo M, Martini A et al..  2023.  miR-218 Promotes Dopaminergic Differentiation and Controls Neuron Excitability and Neurotransmitter Release through the Regulation of a Synaptic-Related Genes Network.. J Neurosci. 43(48):8104-8125.
Kepp O, Liu P, Kroemer G, Galluzzi L.  2023.  A mitochondrial checkpoint to adaptive anticancer immunity.. Oncoimmunology. 12(1):2271693.
Soler-Agesta R, Anel A, Galluzzi L.  2023.  Mitochondrial control of antigen presentation in cancer cells.. Cancer Cell. 41(11):1849-1851.
Marchi S, Guilbaud E, Tait SWG, Yamazaki T, Galluzzi L.  2023.  Mitochondrial control of inflammation.. Nat Rev Immunol. 23(3):159-173.
Schweickart A, Batra R, Neth BJ, Martino C, Shenhav L, Zhang AR, Shi P, Karu N, Huynh K, Meikle PJ et al..  2023.  A Modified Mediterranean Ketogenic Diet mitigates modifiable risk factors of Alzheimer's Disease: a serum and CSF-based metabolic analysis.. medRxiv.
Maura F, Ziccheddu B, Xiang JZ, Bhinder B, Rosiene J, Abascal F, Maclachlan KH, Eng KWha, Uppal M, He F et al..  2023.  Molecular Evolution of Classic Hodgkin Lymphoma Revealed Through Whole-Genome Sequencing of Hodgkin and Reed Sternberg Cells.. Blood Cancer Discov. 4(3):208-227.
Benedetti E, Liu EMinwei, Tang C, Kuo F, Buyukozkan M, Park T, Park J, Correa F, A Hakimi A, Intlekofer AM et al..  2023.  A multimodal atlas of tumour metabolism reveals the architecture of gene-metabolite covariation.. Nat Metab. 5(6):1029-1044.
Scarpa JR, Elemento O.  2023.  Multi-omic molecular profiling and network biology for precision anaesthesiology: a narrative review.. Br J Anaesth. 131(1):26-36.
Song W-M, Elmas A, Farias R, Xu P, Zhou X, Hopkins B, Huang K-L, Zhang B.  2023.  Multiscale protein networks systematically identify aberrant protein interactions and oncogenic regulators in seven cancer types.. J Hematol Oncol. 16(1):120.
Mlynarczyk C, Teater M, Pae J, Chin CR, Wang L, Arulraj T, Barisic D, Papin A, Hoehn KB, Kots E et al..  2023.   mutation yields supercompetitive B cells primed for malignant transformation.. Science. 379(6629):eabj7412.
Hussain M, Sternberg CN, Efstathiou E, Fizazi K, Shen Q, Lin X, Sugg J, Steinberg J, Noerby B, De Giorgi U et al..  2023.  Nadir Prostate-specific Antigen as an Independent Predictor of Survival Outcomes: A Post Hoc Analysis of the PROSPER Randomized Clinical Trial.. J Urol. 209(3):532-539.
Altorki NK, Walsh ZH, Melms JC, Port JL, Lee BE, Nasar A, Spinelli C, Caprio L, Rogava M, Ho P et al..  2023.  Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial.. Nat Commun. 14(1):8435.
Bamias A, Merseburger A, Loriot Y, James N, Choy E, Castellano D, Lopez-Rios F, Calabrò F, Kramer M, de Velasco G et al..  2023.  New prognostic model in patients with advanced urothelial carcinoma treated with second-line immune checkpoint inhibitors.. J Immunother Cancer. 11(1)
Barnes J, Brendel M, Gao VR, Rajendran S, Kim J, Li Q, Malmsten JE, Sierra JT, Zisimopoulos P, Sigaras A et al..  2023.  A non-invasive artificial intelligence approach for the prediction of human blastocyst ploidy: a retrospective model development and validation study.. Lancet Digit Health. 5(1):e28-e40.
Fornarini G, Rebuzzi SE, Buti S, Rescigno P, Merseburger A, Sternberg CN, De Giorgi U, Basso U, Maruzzo M, Giannatempo P et al..  2023.  A novel immunotherapy prognostic score for patients with pretreated advanced urInary TrAct CArcinoma from the subgroup analysis of the SAUL study: the ITACA Score.. Minerva Urol Nephrol. 75(3):308-318.
Bhardwaj P, Iyengar NM, Zahid H, Carter KM, Byun DJun, Choi MHo, Sun Q, Savenkov O, Louka C, Liu C et al..  2023.  Obesity promotes breast epithelium DNA damage in women carrying a germline mutation in .. Sci Transl Med. 15(684):eade1857.
Lauritsen J, Sauvé N, Tryakin A, Jiang DMaria, Huddart R, Heng DYC, Terbuch A, Winquist E, Chovanec M, Hentrich M et al..  2023.  Outcomes of relapsed clinical stage I versus de novo metastatic testicular cancer patients: an analysis of the IGCCCG Update database.. Br J Cancer. 129(11):1759-1765.
Vanpouille-Box C, Galluzzi L.  2023.  p53 regulates the mitochondrial immune checkpoint.. Trends Immunol. 44(4):245-247.
Li Y, Porta-Pardo E, Tokheim C, Bailey MH, Yaron TM, Stathias V, Geffen Y, Imbach KJ, Cao S, Anand S et al..  2023.  Pan-cancer proteogenomics connects oncogenic drivers to functional states.. Cell. 186(18):3921-3944.e25.